Pérez GJH, Cruz RN, Sánchez CAR

Language: Spanish
References: 20
Page: 137-143
PDF size: 236.21 Kb.

ABSTRACT

Cerebral venous thrombosis is a rare entity with widely variable clinical signs; thus, a high degree of suspicion is required for diagnosis. It affects the dural sinuses and may or may not invade cerebral veins. The diagnosis has usually been based on an angiographic study although, at the present time, new noninvasive imaging techniques, such as computed tomography, magnetic resonance and magnetic resonance angiography, are being employed in a growing number of cases. Treatment should involve symptomatic and etiologic therapy. Although anticoagulation would appear to be a reasonable option in these patients, it remains controversial. As in other processes such as pulmonary embolism and coronary thrombosis, the introduction of novel and increasingly safe fibrinolytic drugs, together with technical innovations in the field of interventional neuroradiology, is changing the perspectives for the management of these patients. We present the case of a 46-year-old woman with right sinus thrombosis who was treated with anticoagulation. The authors describe the technique employed and review the literature.

REFERENCES

1. Guerra F. Avances recientes en el diagnóstico y tratamiento de la trombosis venosa cerebral. Medicina Universitaria 2002; 4(14): 15-27.

2. Pujol A, Páramo J. Complicaciones clínicas en una serie de pacientes con anticuerpos anticardiolipina.

3. Suárez AL, Graham RV, Hughes. Manifestaciones neurológicas en el síndrome antifosfolipídico. Med Clin (Barc) 2005; 124: 630-3.

4. Tapia J. Enfermedad cerebrovascular y trombofilia. Rev Chil Neuro-Psiquiatr 2002; 40(2).

5. Gonzáles B. Trombosis venosa cerebral y anticonceptivos. Rev de Ginecología y Obstetricia 2004; 31(9): 342-5.

6. Hurtado Montalbán. Papiledema secundario a trombosis cerebral de los senos venosos. Archivos de la Sociedad Española de Oftalmología 2001; 12.

7. Franco E, Gil E. Trombosis venosa cerebral profunda puerperal. Rev Neurol 1999; 29(8): 722-4.

8. Blasco B. Trombosis venosa intracraneales. Rev Neurol 2002; 25(140): 569-75.

9. Duran P. Anticoagulación oral. An Med Interna (Madrid) 2003; 20(7).

10. Röttger C. Is Heparin Treatment the Optimal Management for Cerebral Venous Thrombosis? Effect of Abciximab, Recombinant Tissue Plasminogen Activator, and Enoxaparin in Experimentally Induced Superior Sagittal Sinus Thrombosis. Stroke 2005; 36: 841.

11. Steve G, Sutton A. Meta-Analysis: The Value of Clinical Assessment in the Diagnosis of Deep Venous Thrombosis. 19 2005; 143(2): 129-39.

12. Vessey MP, Hannaford P. Oral contraception and eye disease: findings in two large cohort studies. Br J Ophthalmol 1998; 82: 538-42.

13. Delgado F. Trombosis venosa cerebral. Tratamiento mediante fibrinólisis local con alteplasa. 2002; 44(1): 23-6.

14. Scoditti U, Buccino GP. Risk of acute cerebrovascular events related to low oestrogen oral contraceptive treatment. Ital J Neurol Sci 1998; 19: 15-9.

15. Farley TM. Combined oral contraceptives, smoking, and cardiovascular risk. J Epidemiol Community Health 1998; 52: 775-85.

16. Zaoui M, Cordebar B. Central retinal vein occlusion in a patient treated with antiandrogenic drug. J Fr Ophtalmol 2000; 23: 42-4.

17. Benavides E, Tapia J. Enfermedad cerebrovascular asociada a uso de anticonceptivos orales. Rev Med Chile 2002; 26.

18. Pérez F, Bartolomé A. Accidentes vasculares en oftalmología y anticonceptivos orales. Archivos de la Sociedad Española de Oftalmología 2002; 3-16.

19. Guevara O. Estados de hipercoagulabilidad heredados y trombosis venosa cerebral. Experiencia en 3 casos. Rev Med Chile 2002; 130(1).

20. Douketis J. Use of a Clinical Prediction Score in Patients with Suspected Deep Venous Thrombosis: Two Steps Forward, One Step Back? Ann Intern Med 2005; 143(2): 140-2.